published meta-analysis   sensitivity analysis   studies

standard of care in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias deathsdetailed resultsEntrenas (Pilot Calcifediol), 2020 (REV) 8.25 [0.36; 190.06] 8.25[0.36; 190.06]Entrenas (Pilot Calcifediol), 2020 (REV)10%76NAnot evaluable ICU admissiondetailed resultsOut of scaleEntrenas (Pilot Calcifediol), 2020 (REV) 33.33 [3.65; 304.29] 33.33[3.65; 304.29]Entrenas (Pilot Calcifediol), 2020 (REV)10%76NAnot evaluable0.520.01.0relative treatment effectwww.metaEvidence.org2024-06-07 12:26 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 651 - roots T: 651